BioMarin Pharmaceutical Inc. was founded in 1997, and since July 1999 the company's common stock has been traded on the Nasdaq National Market under the ticker symbol BMRN. BioMarin's policy is to fully comply with all rules put forth by the Securities and Exchange Commission and the Nasdaq National Market. For misplaced stock certificates, please contact our transfer agent directly.
Events & Presentations
BMN 270 Data Update at the World Federation of Hemophilia Congress 2016
Jul 27, 2016 at 4:05 PM ET